Medicinal Plants Research in Nigeria: An Output Analysis


  • Conrad A. Omonhinmin Department of Biological Sciences, College of Science and Technology. Covenant University, Km. 10 Idiroko road, Ota, P.M.B. 1022, Ogun State, Nigeria
  • Ibukun B. Ajiboye Department of Biological Sciences, College of Science and Technology. Covenant University, Km. 10 Idiroko road, Ota, P.M.B. 1022, Ogun State, Nigeria


Medicinal plant, Nigeria, Scientometric, Dimensions


Global renewed interest in medicinal plants, the place of Nigeria with a sizeable population of researchers and an accompanying biological and cultural diversity to instigate a wide range of plant’s applications as medicine, motivated the present study to evaluate the volume, spread, and progression in scholarly publications on medicinal plants, with top countries in perspective. The study accessed publications (2009 – 2018) by DIMENSIONS® internet platform links with over 124 million documents and Citation Data in various subject areas. A total hit of 33, 071 retrieved medicinal plant publications of Nigerian affiliation were analyzed with decreased annual percentage output of 15.22% in 2009 to 10.06% in 2017, and 12.37% in 2018. The 10 top journal outlets, subject areas and productive authors of Nigerian affiliations accounted for 9.94%, 32.95%, and a 1.58% share of total medicinal plant publication output. Country-wise, the productivity profile shares of the analyzed en countries varied widely, from -3% to 64% for the period between 2009-2013 and 2014-2018 and positional change among the countries oscillated over the study period. The observed trend buttresses the need to challenge the present state of medicinal plant publication output, particularly in Nigeria, for rigorous research productivity and commensurate funding. 


Alhaider I, Ahmed KM, Gupta B. Pharmaceutical research in the Kingdom of Saudi Arabia: A scientometric analysis during 2001–2010. Saudi Pharm J. 2015; 23(3):215-222.

Sedighi M, Bahmani M, Asgary S, Beyranvand F, Rafieian-Kopaei M. A review of plant-based compounds and medicinal plants effective on atherosclerosis. J Res Med Sci. 2017; 22(1):30

Fedotova J, Kubatka P, Büsselberg D, Shleikin AG, Caprnda M, Dragasek J, Rodrigo L,Pohanka M, Gasparova I, Nosal V. Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts. Biomed Pharmacother. 2017; 95:437-446.

Mahesh B and Satish S. Antimicrobial Actiity of some Important Medicinal Plants Against Plant and Human Pathogens. World J Agric Res. 2008; 4(5):839-843.

Brevoort P. US botanical market--an overview. HerbalGram. 1996.

Blumenthal M. Herb industry sees mergers, acquisitions, and entry by pharmaceutical giants in 1998. HerbalGram. 1999; 45:67-68.

Conrad OA, Dike IP, Agbara U. In vivo antioxidant assessment of two antimalarial plants–Allamamda cathartica and Bixa orellana. Asian Pac J Trop Med. 2013; 3(5):388-394.

Popoola JO, Aworunse OS, Oyesola OL, Akinnola OO, Obembe OO. A systematic review of pharmacological activities and safety of Moringa oleifera. J Herbmed Pharmacol. 2020; 9(3):174-190.

WHO. Traditional medicine; growing needs and potential. WHO Policy Perspectives on medicines. Geneva: WHO. 2002; 6:1-6.

WHO. Legal status of traditional medicine and complementary. Geneva. World Health Organization. 2001; 9241545488.

Borokini TI and Omotayo FO. Phytochemical and ethnobotanical study of some selected medicinal plants from Nigeria. J Med Plant Res. 2012; 6(7):1106-1118.

Sofowora E. The state of Medicinal Plants' Research in Nigeria. Ibadan University Press, Nigeria, 1982.404 p.

WHO. Resolution-promotion and development of training and research in traditional medicine. WHO document. 1977; 30:49-50.

Garfield E. How to Use Citation Analysis for Faculty Evaluations and When Is It Relevant? Curr Contents. 1983; 44:5-13.

Katz JS and Hicks D. A systemic view of British science. Scim. 1996; 35(1):133-154.

WHO. WHO: Action plan for the Global Strategy for the prevention and control of noncommunicable diseases 2008-2013. Geneva, World Health Assembly: A61/8, World Health Organization: World Health Organization; 2008.

Hughes GD, Aboyade OM, Beauclair R, Mbamalu ON, Puoane TR. Characterizing herbal medicine use for noncommunicable diseases in urban South Africa. Evid-Based Compl Altern Med. 2015; 2015:736074.

Kalauni D and Joshi A. Status of Medicinal and Aromatic Plant (MAPs) and Socio-Economic Influence in Nepalese Livelihood- A Review Research. Acta Sci Agric. 2018; 2(9):123-130.

Sharma A, Shanker C, Tyagi LK, Singh M, Rao CV. Herbal medicine for market potential in India: an overview. Acad J Plant Sci. 2008; 1(2):26-36.

Pelkonen O, Xu Q, Fan T-P. Why is research on herbal medicinal products important and how can we improve its quality? J Trad Compl Med. 2014; 4(1):1-7.

Calapai G and Caputi AP. Herbal medicines: can we do without pharmacologist? Evid-Based Compl AlternMed. 2007; 4(S1):41-43.

Jantan I. Medicinal plant research in Malaysia: scientific interests and advances. Malay J Med Health Sci. 2004; 2(2):27-46

Chikezie PC and Ojiako OA. Alternative & Integrative Medicine. Hypertension. 2015; 20:23.

Mashayekhan A, Pourmajidian MR, Jalilvand H, Gholami MR, Teimouri MS. Economic importance and GIS mapping of medicinal plants in Iran: a case study of Darkesh. JASEM. 2016; 20(3):646-650.

Majeed M. Evidence-based medicinal plant products for the health care of world population. Ann Phytomed . 2017; 6(1):1-4.

Anyinam C. Availability, accessibility, acceptability, and adaptibility: Four attributes of African ethnomedicine. Soc Sci Med. 1987; 25(7):803-811.

Al-Snafi AE. Clinically tested medicinal plant: A review (Part 1). SMU Med J. 2016; 3(1):99-128.

Tolossa K, Debela E, Athanasiadou S, Tolera A, Ganga G, JG H. Ethno-medicinal study of plants used for treatment of human and livestock ailments by traditional healers in South Omo, Southern Ethiopia. J Ethnobiol Ethnomed. 2013; 9(1):32.

Jokar NK, Noorhosseini SA, Allahyari MS, Damalas CA. Consumers' acceptance of medicinal herbs: an application of the technology acceptance model (TAM). J Ethnopharmacol. 2017; 2(7):203-210.

Leguizamo MAO, Gómez WDF, Sarmiento MCG. Native herbaceous plant species with potential use in

phytoremediation of heavy metals, spotlight on wetlands—a review. Chemosphere. 2017; 168:1230-1247.

Gupta D, Huang H, Corpas F. Lead tolerance in plants: strategies for phytoremediation. Environ Sci Pollut Res. 2013; 20(4):2150-2161.

Lakey KD. Ecological status of high altitude medicinal plants and their sustainability: Lingshi, Bhutan. BMC Ecol. 2016; 16(1):45.

Birch JL and Keeley SC. Dispersal pathways across the Pacific: the historical biogeography of Astelia sl (Asteliaceae, Asparagales). J Biogeogr. 2013; 40(10):1914-1927.

Chen SL, Yu H, Luo HM, Wu Q, Li C-F, Steinmetz A. Conservation and sustainable use of medicinal plants: problems, progress, and prospects. Chin Med. 2016;11(1):37.

Kayser O. Ethnobotany and medicinal plant biotechnology: from tradition to modern aspects of drug development. Planta Med. 2018; 84(12/13):834-838.

Zulkipli IN, David SR, Rajabalaya R, Idris A. Medicinal plants: a potential source of compounds for targeting cell division. Drug Target Insights. 2015; 9:DTI-S24946.

Wang Ty, Li Q, Ks B. Bioactive flavonoids in medicinal plants: Structure, activity and biological fate. Asian J Pharm Sci. 2018; 13(1):12-23.

Cavender‐Bares J, Gamon JA, Hobbie SE, Madritch MD, Meireles JE, Schweiger AK, et al. Harnessing plant spectra to integrate the biodiversity sciences across biological and spatial scales. . Am J Bot. 2017; 104(7):966-969.

Babar MM, Pothineni VR, Ali Z, Faisal S, Hakeem KR, Gul A. Application of bioinformatics and system biology in medicinal plant studies. Plant Bioinformatics: Springer 2017. 375-93 p.

Singh S, Singh DB, Singh S, Shukla R, Ramteke PW, Misra K. Exploring medicinal plant legacy for drug discovery in post-genomic era. Proceedings of the National Academy of Sciences, India Section B: Bio Sci. 2019; 89(4):1141-1151.

Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. 2019; 9(11):258.

De Freitas Araújo MG and Bauab TM. Microbial quality of medicinal plant materials. Latest Res Qual Contr. Intechopen; 2012. 67-81 p.

Martins HnM, Martins MLg, Dias MI, Bernardo F. Evaluation of microbiological quality of medicinal plants used in natural infusions. Int J Food Microbiol. 2001; 68(1-2):149-153.

Christian N, Whitaker BK, Clay K. Microbiomes: unifying animal and plant systems through the lens of community ecology theory. Front Microbiol. 2015; 6:869.

Marcelo G, de Freitas ATM. Microbial quality of medicinal plant materials. . In: Akyar I, editor. Latest Res Quality Control. London: Intechopen; 2012.

Tennant JP, Waldner F, Jacques DC, Masuzzo P, Collister LB, Hartgerink CH. The academic, economic and societal impacts of Open Access: an evidencebased review. F1000Research. 2016; 5.

Fuchs C and Sandoval M. The diamond model of open access publishing: Why policy makers, scholars, universities, libraries, labour unions and the publishing world need to take non-commercial, non-profit open access serious. TripleC: Communication, capitalism & critique. 2013; 11(2):428-443.

Björk BC. Gold, green, and black open access. Learn Publ. 2017; 30(2):173-175.




How to Cite

Omonhinmin, C. A., & Ajiboye, I. B. (2021). Medicinal Plants Research in Nigeria: An Output Analysis: Tropical Journal of Natural Product Research (TJNPR), 5(1), 1–6. Retrieved from